The Promise of Purity

WIPO WIPO 2017

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark The Promise of Purity was filed as Word mark on 07/18/2017 at the World Intellectual Property Organization.

Trademark Details Last update: April 26, 2022

Trademark form Word mark
File reference 1363126
Countries Benelux Switzerland China Germany European Community Spain France India Italy Japan South Korea Mexico
Base trademark US No. 87307429, January 19, 2017
Application date July 18, 2017
Expiration date July 18, 2027

Trademark owner

1219 Glen Rock Avenue
Waukegan IL 60085
US

Trademark representatives

250 West 55th Street New York NY 10019-9710 US

goods and services

01 Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
42 Biochemical research and development; chemical, biochemical, biological and bacteriological research and analysis; drug discovery services; pharmaceutical drug development services; product research and development; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines

Trademark history

Date Document number Area Entry
March 28, 2022 2022/17 Gaz IN Rejection
October 5, 2020 2020/44 Gaz FR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 24, 2020 2020/40 Gaz DE Rejection
September 22, 2020 2020/39 Gaz IT Rejection
July 2, 2020 2020/27 Gaz BX Rejection
June 10, 2020 2020/24 Gaz ES Rejection
April 9, 2020 2020/16 Gaz CH Rejection
February 21, 2020 2020/10 Gaz DE Rejection
February 10, 2020 2020/8 Gaz FR Rejection
July 18, 2019 2019/30 Gaz EM Rejection
April 10, 2019 2019/17 Gaz US Correction
December 28, 2018 2019/3 Gaz CN Rejection
September 19, 2018 2018/39 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
June 28, 2018 2018/27 Gaz MX Rejection
March 16, 2018 2018/12 Gaz KR Rejection
March 15, 2018 2018/11 Gaz JP Rejection
October 12, 2017 2017/44 Gaz EM Rejection
September 18, 2017 2017/39 Gaz IN Rejection
August 31, 2017 2019/39 Gaz EM RAW: Subsequent Designation Resulting From Conversion
July 18, 2017 2017/33 Gaz US Registration

ID: 141363126